Disclosures for "Population Pharmacokinetic Modeling of Riluzole After Administration of a Next Generation Prodrug Troriluzole"
-
Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
-
Dr. Pene Dumitrescu has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allucent. Dr. Pene Dumitrescu has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TEVA Pharmaceutics. Dr. Pene Dumitrescu has stock in GlaxoSmithkline.
-
Dr. Wu has received personal compensation for serving as an employee of Biogen, Inc.. Dr. Wu has received personal compensation for serving as an employee of Allucent, Inc.. Dr. Wu has stock in Biogen, Inc..
-
Dr. Jeong has received research support from Allucent.
-
Ms. Sevinsky has received personal compensation for serving as an employee of Biohaven. Ms. Sevinsky has stock in Biohaven.
-
Dr. Qureshi has received personal compensation for serving as an employee of Biohaven.
-
Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.